Study Censored by The Lancet Finally Released: Confirms ‘High Likelihood of Causal Link Between COVID-19 Vaccines and Death’

Posted on | Posted on John Murphy | Leave a Comment on Study Censored by The Lancet Finally Released: Confirms ‘High Likelihood of Causal Link Between COVID-19 Vaccines and Death’

On November 17, 2024, Science, Public Health Policy and The Law journal published a peer-reviewed study titled, “A Systematic Review Of Autopsy Findings In Deaths After Covid-19 Vaccination.“ This study was publicly available, but publications such as The Lancet made repeated attempts to censor it. After far too long, it has finally been published. Coincidentally, […]

NIH to open long COVID clinical trials to study sleep disturbances, exercise intolerance, and post exertional malaise

Posted on | Posted on John Murphy | Leave a Comment on NIH to open long COVID clinical trials to study sleep disturbances, exercise intolerance, and post exertional malaise

Part of the NIH RECOVER Initiative, trials will test four treatments. The National Institutes of Health (NIH) will launch clinical trials to investigate potential treatments for long-term symptoms after COVID-19 infection, including sleep disturbances, exercise intolerance and the worsening of symptoms following physical or mental exertion known as post-exertional malaise (PEM). The mid-stage trials, part […]

Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC) up to 15 Months Post-Infection

Posted on | Posted on John Murphy | Leave a Comment on Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC) up to 15 Months Post-Infection

Authors: Bruce K. Patterson, 1 , * Edgar B. Francisco, 1 Ram Yogendra, 2 et. al., Front Immunol. 2021; 12: 746021.Published online 2022 Jan 10. doi: 10.3389/fimmu.2021. 746021PMCID: PMC8784688PMID: 35082777 Abstract The recent COVID-19 pandemic is a treatment challenge in the acute infection stage but the recognition of chronic COVID-19 symptoms termed post-acute sequelae SARS-CoV-2 infection (PASC) may affect up to 30% of all infected individuals. The […]

The Link Between Blood Types And Risks of COVID-19, Cancer, And Other Diseases

Posted on | Posted on John Murphy | Leave a Comment on The Link Between Blood Types And Risks of COVID-19, Cancer, And Other Diseases

Authored by Ellen Wan via The Epoch Times Blood types play a crucial role not only in ensuring safe blood transfusions but also in influencing various health risks. Numerous studies suggest that genetically determined blood types may increase susceptibility to both infectious and non-infectious diseases, including COVID-19, heart disease, and allergies. Blood is categorized into four main types—A, […]

Study Finds 1 in 4 Americans May Have Long COVID

Posted on | Posted on John Murphy | Leave a Comment on Study Finds 1 in 4 Americans May Have Long COVID

By Lynn C. Allison, A newly released study finds that one in four Americans may suffer from long COVID, a much higher rate than typically cited. Scientists at Mass General Brigham used a sophisticated AI tool for the peer-reviewed study. While the Centers for Disease Control and Prevention suggested that in 2022 roughly 6.9% of Americans […]

Mesenteric Panniculitis and COVID-19: A Rare Association

Posted on | Posted on John Murphy | Leave a Comment on Mesenteric Panniculitis and COVID-19: A Rare Association

Authors: Israa A Alyousef,1Zainab A Alsaileek,1Manar A Alabdulsalam,1et. al. Cureus. 2022 Jan; 14(1): e21314. . doi: 10.7759/cureus.21314 PMCID: PMC8849467PMID: 35186573 Abstract Coronavirus disease 2019 (COVID-19) typically involves the respiratory system, but gastrointestinal involvement is common. Further, patients with severe COVID-19 are at high risk to develop gastrointestinal complications, including bowel ischemia, ileus, and deranged liver enzymes. We present the case […]

Role of 2-Deoxy-D-Glucose in Enhancing the Efficacy of Standard of Care for Moderate to Severe COVID-19: A Comparative Analysis of Clinical Outcomes

Posted on | Posted on John Murphy | Leave a Comment on Role of 2-Deoxy-D-Glucose in Enhancing the Efficacy of Standard of Care for Moderate to Severe COVID-19: A Comparative Analysis of Clinical Outcomes

Triven Sagar Sandepogu • Chennakesavulu Dara • Saranya Mallamgunta •, et. al. DOI: 10.7759/cureus.73993  Abstract Objective This study aimed to evaluate the role of 2-Deoxy-D-Glucose (2-DG) in moderate to severe Coronavirus Disease 2019 (COVID-19) cases. Methodology This study retrospectively analyzed the effects of 2-DG alongside Standard of Care (SOC) for moderate to severe COVID-19 in 150 patients. Eligible patients were aged […]

Threatening Eye Condition Rare After COVID Infection

Posted on | Posted on John Murphy | Leave a Comment on Threatening Eye Condition Rare After COVID Infection

Authors: Steven Reinberg, US News & World Report As doctors learn more about COVID-19 infection, they are finding that in rare cases, it appears tied to a disturbing eye condition. Retinal vein occlusion is a blockage of the small veins that carry blood away from the retina, which causes blurred vision. It usually occurs in people […]

New-onset chronic musculoskeletal pain following COVID-19 infection fulfil the Fibromyalgia clinical syndrome criteria

Posted on | Posted on John Murphy | Leave a Comment on New-onset chronic musculoskeletal pain following COVID-19 infection fulfil the Fibromyalgia clinical syndrome criteria

Omar Khoja, Matthew Mulvey, Sarah Astill,  et. al. doi: https://doi.org/10.1101/2024.07.10.24310234 Abstract Background: New-onset chronic musculoskeletal (MSK) pain (> 3 months duration) is one of the commonest persistent symptoms of Post-COVID syndrome (PCS). There is emerging evidence that the chronic MSK pain and associated symptoms in PCS have similarities to Fibromyalgia Syndrome (FMS). This study aimed to characterise PCS related new-onset chronic MSK […]

Kansas City Attorney General’s legal report on the case against Pfizer

Posted on | Posted on John Murphy | Leave a Comment on Kansas City Attorney General’s legal report on the case against Pfizer

BY CARL HENEGHAN, 2024  PHARMA, VACCINES   We’ve extracted the main points from the Kansas City Attorney General’s legal report on the case against Pfizer that we first mentioned in Due Process—all quotes are taken verbatim. This is a lengthy post, and we’d recommend having an anger management strategy to hand while reading. If you are making a comment, […]